Skip to main content

Table 3 Pregnancy outcomes of two treatment protocols

From: Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis

 

Original cohort

P

PSM cohort

P

Group A (n = 168)

Group B (n = 114)

Group A (n = 71)

Group B (n = 71)

Clinical pregnancy rate (n, %)

83 (49.40%)

73 (64.04%)

0.015

33 (46.48%)

43 (60.56%)

0.130

Miscarriage rate (n, %)

21 (12.50%)

20 (17.54%)

0.238

10 (14.09%)

11 (15.49%)

0.813

Early miscarriage

17(10.12%)

17(14.91%)

0.225

8(11.27%)

10(14.08%)

0.796

Late miscarriage

4(2.38%)

3(2.63%)

0.894

2(2.81%)

1(1.41%)

0.560

Live birth rate (n, %)

62 (36.90%)

52 (45.61%)

0.144

23 (32.39%)

32 (45.07%)

0.168

Single/twin

  

0.079

  

0.214

 Single (n, %)

57(91.94%)

42(80.77%)

 

20 (86.96%)

25 (78.12%)

 

 Twin (n, %)

5(8.06%)

10(19.23)

 

3 (13.04%)

7 (21.88%)

 

Preterm delivery rate (n, %)

15 (8.93%)

15 (13.16%)

0.258

5 (7.04%)

11 (15.49%)

0.185

Cumulative live birth rate (n, %)

87/168(51.79%)

73/114(64.04%)

0.042

39/71(54.90%)

43/71(60.60%)

0.610

  1. Note: Group A = GnRH antagonist protocol and freeze-all strategy; Group B = long-acting GnRH agonist protocol; PSM = propensity-score matching